Proactive Investors - Run By Investors For Investors

PURE Bioscience expects to break even on cash-flow early 2019

PURE Bioscience Inc (OTCMKTS:PURE) CEO Henry Lambert sat down with Proactive Investors at the 11th Annual LD Micro Main Event in Los Angeles. 

The El Cajon, California-based company develops and commercializes antimicrobial products. It makes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection. The company sells SDC-based formulations to personal care product manufacturers. It also offers SDC-based disinfecting and sanitizing products, including PURE Hard Surface, PURE Control, PURE Multi-Purpose and Floor Cleaner Concentrate and PURE Multi-Purpose Hi-Foam Cleaner Concentrate.

Meet ICOx Innovations at our event, New York , 30 January 2019. Register here »
View full PURE profile View Profile

PURE Bioscience Timeline

Copyright ©, 2018. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use